Ocular Therapeutix, Inc. (OCUL) Financials

OCUL Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 732.5 million 151.0 million
Dec. 31, 2025 808.1 million 153.7 million
Sept. 30, 2025 410.9 million 152.7 million
June 30, 2025 451.3 million 145.4 million

OCUL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -70.7 million 15.6 million
Dec. 31, 2025 -57.1 million 11.4 million
Sept. 30, 2025 -56.7 million 11.7 million
June 30, 2025 -56.5 million 9.7 million

OCUL Net Income

No data available :(

OCUL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 666.7 million 72.1 million 4.2 million
Dec. 31, 2025 737.1 million 71.3 million 5.6 million
Sept. 30, 2025 344.8 million 70.6 million 6.4 million
June 30, 2025 391.1 million 69.9 million 7.0 million

OCUL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 224.1 million
Dec. 31, 2025 222.9 million
Sept. 30, 2025 183.9 million
June 30, 2025 172.6 million

OCUL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4.7 million 66.2 million 36.6 million 16.6 million
Dec. 31, 2025 2.8 million 50.8 million 30.6 million 13.0 million
Sept. 30, 2025 6.0 million 52.4 million 29.1 million 13.1 million
June 30, 2025 1.2 million 51.1 million 28.1 million 1.5 million

OCUL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 10.8 million 1.3 million
Dec. 31, 2025 13.3 million 1.6 million
Sept. 30, 2025 14.5 million 1.8 million
June 30, 2025 13.5 million 1.9 million

OCUL Revenue by Segment
Graph available only for paid members. Upgrade to see it.

OCUL

Price: $8.99

52 week price:
6.23
16.44

Payout Ratio Range:
-158.37%
-1.71%

Earnings Per Share: -1.44 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 567800

Ebitda: -14.6 million

Market Capitalization: 1.8 billion

Links: